Kidney resident macrophages in the rat have minimal turnover and replacement by blood monocytes

Author(s):  
Kurt Zimmerman ◽  
Zhengqin Yang ◽  
Jeremie M Lever ◽  
Zhang Li ◽  
Mandy J Croyle ◽  
...  

Kidney resident macrophages (KRM) are involved in maintaining renal homeostasis and in controlling the pathological outcome of acute kidney injury and cystic kidney disease in mice. In adult mice, KRM maintain their population through self-renewal with little or no input from the peripheral blood. Despite recent data suggesting that a transcriptionally similar population of KRM-like cells is present across species, the idea that they are self-renewing and independent of peripheral blood input in other species has yet to be proven due to the lack of an appropriate model and cross-species expression markers. In this study, we use our recently identified cross-species KRM cell surface markers and parabiosis surgery in inbred Lewis rats to determine if rat KRM are maintained independent of peripheral blood input, similar to their mouse counterparts. Flow cytometry analysis indicates that parabiosis surgery in the rat results in establishment of chimerism of T/B cells, neutrophils, and monocyte-derived infiltrating macrophages in the blood, spleen, and kidney three weeks post parabiosis surgery. Analysis of KRM using the cell surface markers CD81 or C1q indicates that these cells have minimal chimerism and, therefore, receive little input from the peripheral blood. Thus, a putative KRM population in the rat identified using two novel cross-species markers is maintained with minimal input from the peripheral blood confirming that KRM properties are conserved in at least two different species.

2011 ◽  
Vol 16 (7) ◽  
pp. 744-754 ◽  
Author(s):  
Tyrone Bowes ◽  
Shirley A. Hanley ◽  
Aaron Liew ◽  
Marc Eglon ◽  
Kaveh Mashayekhi ◽  
...  

This study aims at generating immune chicken phage display libraries and single-chain antibodies (scFvs) specifically directed against cell surface markers of cultured peripheral blood mononuclear cells (PBMCs) that contain endothelial progenitor cells (EPCs). In contrast to previous approaches that use well-defined recombinant antigens attached to plastic surfaces that may alter the structure of the proteins, the authors describe a method that maintains the cell surface markers on live cells while providing the opportunity to rapidly screen entire libraries for antibodies that bind to unknown cell surface markers of progenitor/stem cells. Chickens immunized with live EPCs, consisting of a heterogeneous population of lymphocytes and monocytes, demonstrated a robust immune response. After three rounds of biopanning, the authors purified and characterized three unique scFvs called UG1-3. Codon-optimized recombinant UG1 (gUG-1) shows binding by flow cytometry to circulating CD14-positive cells in peripheral blood consistent with predominant expression of a target protein on monocyte subsets. The authors describe the successful use of immunization of chickens for the generation of scFvs against a heterogenous population of EPCs displaying unknown cell surface markers and demonstrate the strong potential of phage display technology in the development of reagents for the isolation and characterization of stem/progenitor cells.


Blood ◽  
2008 ◽  
Vol 112 (11) ◽  
pp. 5402-5402
Author(s):  
Nira Varda-Bloom ◽  
Tatiana Kniazhansky ◽  
Arnon Nagler ◽  
Avraham J Treves

Abstract Pluripotent stem cells are valuable sources for transplantation and tissue repair. The bone-marrow, umbilical cord blood and G-CSF mobilized peripheral blood are the main sources for adult stem cells. Non-mobilized peripheral blood contains mostly committed cells but recent studies suggest the presence of early progenitor and stem cells as well. Here we aim to develop a method to enrich and recover functional progenitor cell populations from non-mobilized peripheral blood. The ex-vivo enriched non-mobilized PBMNCs were tested by FACS analysis of specific cell surface markers, and by functional analysis of differentiation into different cells lineages. Non mobilized PBMNCs obtained from consenting healthy donors (n=18) cultured for 7 days in a defined cytokine cocktail media were analyzed by FACS using CD14, CD31, CD34, CD45, CD90, CD105, CD117 and CD133 and compare to non-manipulated PBMNCs. The enriched cells were also tested for their differentiation capacity into hematopoietic, endothelial and mesenchymal cells lineages compared to non-manipulated PBMNCs. We found that the enriched PBMNCs resulted in two distinct subpopulations, adherent and non adherent, that present different cell surface markers and have different differentiation capacities. Cell surface markers analysis showed that adherent cells possess high percentage of CD14 (28.1 ±6.13, 11.8 ± 3.9), CD90 (4.24±0.94, 1.53 ± 0.28), CD105 (42.19±8.42, 7.96 ± 4.8), CD117 (9.89±5.99, 1.75± 0.8) expression and reduction of CD45 (46.3±8.14, 62.74± 9.6), CD31 (5.9±1.9, 15.34 ± 4.9) and CD34 (0.18±0.03, 0.62 ±0.3) compare to non-manipulated PBMNCs, respectively. On the other hand, the non-adherent sub-population expresses more CD34 (1.2±0.02, 0.16±0.02), KDR (3.62±0.82, 0.49±0.2), CD105 (21.62±1.85, 7.96 ± 4.8) and CD45 (88.7±0.51, 62.74± 9.6) compared to non-manipulated PBMNCs, respectively. The adherent cells subpopulation showed higher differentiation potential into endothelial (116+23.1 EC colonies/106 cells), mesenchymal (400±53.9 CFU-F/106 cells) lineages compare to non-adherent cells (4.9±1.7 EC colonies/106 cells, 200±29.5 CFU-F/106 cells) and compare to non-manipulated PBMNCs (11.4±1.4 EC colonies/106 cells and 2.5±0.08 CFU-F/106 cells). The non-adherent subpopulations showed higher differentiation potential into hematopoietic colonies (445±75 CFU/106 cells) compared to the adherent sub-population (41.2±24.8 CFU/106 cells), and compared to the non-manipulated PBMNCs (373±39.7 CFU/106 cells) of total colony numbers/106 cells. All results (n=18) are presented as (mean ± SE). In summary, our ex-vivo enrichment methodology yields two different subpopulations with enriched hematological lineage in the non-adherent fraction and enriched endothelial and mesenchymal lineages in the adherent fraction. The ability to obtain enriched populations of endothelial, mesenchymal and hematopoietic progenitors from non mobilized peripheral blood cells may have an important clinical application.


Sign in / Sign up

Export Citation Format

Share Document